Why No One Talks Cournot, Hollywood vs. Seedance 2.0, Micron’s $200B Bet | Jon Caramanica, Haseeb Qureshi, Spenser Skates, Celine Halioua, Ankur Goyal, Reed Duchscher

Why No One Talks Cournot, Hollywood vs. Seedance 2.0, Micron’s $200B Bet | Jon Caramanica, Haseeb Qureshi, Spenser Skates, Celine Halioua, Ankur Goyal, Reed Duchscher

February 17, 2026 3 hr 29 min
🎧 Listen Now

🤖 AI Summary

Overview

This episode dives into a variety of topics, including the Cournot Equilibrium's relevance to AI labs, the evolving dynamics of the music and entertainment industries, major investments in AI infrastructure, and the intersection of crypto and AI. Guests include experts from diverse fields such as music criticism, SaaS, crypto, biotech, and AI observability, each sharing insights into their respective industries.

Notable Quotes

- Crypto was really designed for machines more than it was designed for humans. - Haseeb Qureshi, on the role of crypto in enabling AI agents.

- The new key moat in SaaS is speed of innovation. If you're not pushing the bleeding edge, you're falling behind. - Spenser Skates, on the future of SaaS in the AI era.

- Improving metabolic fitness improves basically everything downstream of that. - Celine Halioua, on the parallels between GLP-1 drugs and longevity treatments.

🧠 The Cournot Equilibrium and AI Labs

- Jordi Hays and John Coogan discuss the Cournot Equilibrium, a concept in economics where a few dominant players in a market influence supply and pricing.

- Jordi Hays highlights how AI labs are locked in a game of chicken, competing on compute and model advancements.

- Ankur Goyal notes that while new models drive innovation, open-source models are gaining traction for specific use cases, with nearly half of token usage on Braintrust's platform coming from open-source models.

- The conversation explores whether AI labs will eventually resemble hyperscaler clouds like AWS or GCP.

🎵 Viral Music and the Meme Economy

- Jon Caramanica analyzes the viral success of My Granny Got Hit with a Bazooka by Miami XO, emphasizing its adaptability across formats and its meme-driven rise.

- The music industry increasingly leverages virality, with labels retrofitting contracts onto viral hits and using platforms like TikTok for promotion.

- Caramanica notes the collapse of nostalgia timelines, with trends from just a few years ago already being revisited.

💰 Major Investments in AI and Crypto

- The Adani Group announces a $100 billion investment in AI infrastructure, aiming to position India as a global AI leader.

- Micron commits $200 billion to address memory bottlenecks in AI, with plans for new semiconductor factories.

- Haseeb Qureshi discusses Dragonfly Capital's $4 billion fund and the growing intersection of crypto and AI, particularly in enabling financial autonomy for AI agents.

🐾 Biotech and Longevity for Dogs

- Celine Halioua of Loyal shares insights into their $100 million Series C funding, aimed at developing FDA-approved drugs to extend dogs' lifespans.

- The company focuses on metabolic fitness as a key mechanism, drawing parallels to the public's growing understanding of GLP-1 drugs.

- Loyal's strategy includes building a consumer-friendly pharma brand and addressing the unique aging challenges of large dog breeds.

📊 SaaS Innovation and AI Observability

- Spenser Skates of Amplitude emphasizes the importance of rapid innovation in SaaS, stating that existing software is no longer a moat.

- Amplitude has integrated AI to allow users to query data in natural language, democratizing analytics.

- Ankur Goyal of Braintrust highlights the need for AI observability, enabling companies to monitor and optimize AI product performance post-launch.

- Both guests stress the importance of staying at the forefront of technological advancements to maintain competitive advantages.

AI-generated content may not be accurate or complete and should not be relied upon as a sole source of truth.

📋 Episode Description

Sign up for TBPN’s daily newsletter at TBPN.com


  • (00:52) - Why is no one talking about the Cournot Equilibrium?

  • (23:53) - 𝕏 Timeline Reactions

  • (33:04) - Adani Group Unveils $100B AI Investment

  • (35:31) - Micron Bets $200B to End AI Bottleneck

  • (41:01) - Warner Bros Reopens Paramount Talks

  • (43:05) - 𝕏 Timeline Reactions

  • (01:00:54) - Thrive Capital Raises $10B in New Funding

  • (01:02:54) - 𝕏 Timeline Reactions

  • (01:15:20) - Hollywood Responds to Seedance 2.0

  • (01:29:08) - Jon Caramanica, born in 1975, is an American journalist and pop music critic for The New York Times, known for his insightful coverage of hip-hop and popular music. He discusses the viral ascent of "My Granny Got Hit with a Bazooka" by Miami XO, highlighting its rapid memeification and the artist's sudden rise from obscurity. Caramanica examines the song's adaptability across various formats, the music industry's response to such unexpected hits, and the evolving dynamics between virality and artist development.

  • (02:02:17) - Spenser Skates, co-founder and CEO of Amplitude, transitioned from algorithmic trading at DRW Trading Group to leading a product analytics company that went public in 2021. He discusses the benefits of taking Amplitude public, including enhanced talent acquisition and long-term stability, and emphasizes the importance of rapid innovation in the SaaS industry to maintain a competitive edge.

  • (02:24:20) - 𝕏 Timeline Reactions

  • (02:29:16) - Haseeb Qureshi, Managing Partner at Dragonfly Capital, a $4 billion crypto venture firm, discusses the firm's recent announcement of their fourth fund and the evolving landscape of crypto investments. He highlights the increasing intersection of crypto with AI, noting investments in platforms like Polymarket and the acquisition of OpenClaw by OpenAI. Qureshi emphasizes the enduring nature of crypto, its expansion into various sectors, and the growing adoption of stablecoins, particularly in countries with high inflation, despite regulatory challenges.

  • (02:42:42) - Celine Halioua, founder and CEO of Loyal, a biotech company developing drugs to extend dogs' lifespans, discusses the company's recent $100 million Series C funding round, bringing total funding to over $250 million. She emphasizes the primary goal of obtaining FDA approval for their first longevity drug, highlighting that much of the development process involves time-consuming steps like aging studies and regulatory responses. Halioua also notes the impact of GLP-1 drugs on public perception of aging biology, making the concept of aging interventions more tangible and understandable.

  • (02:51:33) - Ankur Goyal, founder and CEO of Braintrust, a company specializing in AI product observability, discusses the challenges of predicting AI product behavior post-launch and emphasizes the importance of monitoring re